Fingolimod Capsule
Product Images NDC 72205-227

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fingolimod (NDC 72205-227). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fingolimod Chemical Structure (Fingo 01)

Chemical structure of Fingolimod chloride, showing its molecular arrangement including a phenyl ring and side chains with hydroxyl and ammonium chloride groups.*

FDA Label Image

Fingo-02 (Fingo 02)

A Kaplan-Meier curve showing the percentage of patients with three-month confirmed progression over time in days for a clinical study. The graph compares Fingolimod Capsules 0.5 mg (solid red line) and placebo (dashed black line), with progression percentages reaching approximately 18% for Fingolimod and 24% for placebo by around 720 days.*

FDA Label Image

Fingolimod-cntr-label (Fingolimod Cntr Label)

Label for Fingolimod Capsules 0.5 mg by Novadoz Pharmaceuticals LLC. The label states it contains 30 capsules and includes storage instructions, manufacturer details (MSN Laboratories Private Limited, India), and distributor information (Novadoz Pharmaceuticals LLC, NJ). The label features dosage strength prominently and includes a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.